Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Journal of the Society for Gynecologic Investigation
|
April 1, 1994
Differentiation-dependent expression of the BCL-2 proto-oncogene in the human trophoblast lineage
N Sakuragi, H Matsuo, G Coukos, et al.
Cancer Gene Therapy
|
April 19, 2000
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy
G Coukos, A Makrigiannakis, S Montas, et al.
EJNMMI Research
|
August 18, 2020
<sup>177</sup>Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcoma
J A Delage, A Faivre-Chauvet, J K Fierle, et al.
Cancer Research
|
June 19, 2001
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
E Y Woo, C S Chu, T J Goletz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 1999
Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer
G Coukos, A Makrigiannakis, E H Kang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2025
Enrichment of CD7<sup>+</sup>CXCR3<sup>+</sup> CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma
R Bartolini, L Trueb, D Daoudlarian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2024
Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis
S Martín-Lluesma, I M Svane, U Dafni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 6, 2018
Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma
Y Guo, J Hu, Y Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2019
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
U Dafni, O Michielin, S Martin Lluesma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2019
Gender medicine and oncology: report and consensus of an ESMO workshop
A D Wagner, S Oertelt-Prigione, A Adjei, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Journal of the Society for Gynecologic Investigation
|
April 1, 1994
Differentiation-dependent expression of the BCL-2 proto-oncogene in the human trophoblast lineage
N Sakuragi, H Matsuo, G Coukos, et al.
Cancer Gene Therapy
|
April 19, 2000
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy
G Coukos, A Makrigiannakis, S Montas, et al.
EJNMMI Research
|
August 18, 2020
<sup>177</sup>Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcoma
J A Delage, A Faivre-Chauvet, J K Fierle, et al.
Cancer Research
|
June 19, 2001
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
E Y Woo, C S Chu, T J Goletz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 1999
Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer
G Coukos, A Makrigiannakis, E H Kang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2025
Enrichment of CD7<sup>+</sup>CXCR3<sup>+</sup> CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma
R Bartolini, L Trueb, D Daoudlarian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2024
Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis
S Martín-Lluesma, I M Svane, U Dafni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 6, 2018
Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma
Y Guo, J Hu, Y Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2019
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
U Dafni, O Michielin, S Martin Lluesma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2019
Gender medicine and oncology: report and consensus of an ESMO workshop
A D Wagner, S Oertelt-Prigione, A Adjei, et al.
Page
of 7